Pain is the most costly chronic health problem in the U.S. In latest RIFs at NIH, an entire division devoted to pain research ...

CHATHAM, NJ / ACCESS Newswire / March 31, 2025 /This post was written and published as a collaboration between the in-house ...

According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...

Viatris reached a $335 million settlement framework to resolve opioid lawsuits, addressing over 1,000 U.S. and Canadian legal ...

Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our ...

Illinois, along with 13 other states, has reached a $335 million settlement with Mylan Inc. over allegations the company deceptively promoted its opioid products as being less prone to abuse.

It's common knowledge that many use cannabis and natural products to treat pain symptoms, especially as the nation reckons ...

Viatris (VTRS) has reached a nationwide settlement framework to resolve opioid-related claims by states, local governments, and Tribes against ...

Implementation of the ERAS program delivers better patient outcomes, achieves shorter lengths of stay, and saves money.

In this multi-part series, benefit advisers share their experiences with alternatives to surgery to treat debilitating and ...

Opioid addiction remains a major public health crisis in the United States, with post-surgical prescriptions often playing a significant role.

The list of treatments for low back pain is endless, but few offer relief for the one in four Americans who suffer from this ...